Dholaria Bhagirathbhai, MBBS, Vanderbilt University Medical Center, Nashville, TN, shares his thoughts on the most exciting data in CAR-T therapy that will be released at this year’s Tandem Meetings, including results from the CARTITUDE-2 (NCT04133636), ELARA (NCT03568461), and ZUMA-5 (NCT03105336) studies. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.
Categories
Exciting CAR-T data in multiple myeloma and follicular lymphoma: CARTITUDE-2, ELARA & ZUMA-5 [Video]
![After the lymphoma diagnosisnext steps [Video]](https://crowd-funding.givetaxfree.org/wp-content/uploads/2022/08/mp_78903_0_0jpg.jpg)
![Mantle Cell Lymphoma (MCL): Oncology Hour [Video]](https://crowd-funding.givetaxfree.org/wp-content/uploads/2022/08/mp_78676_0_0jpg.jpg)
![Light The Late-Night with Charles Esten and Friends [Video]](https://crowd-funding.givetaxfree.org/wp-content/uploads/2021/11/mp_1632_0_relixlogopng.png)
![Leukemia short Urdu video [Video]](https://crowd-funding.givetaxfree.org/wp-content/uploads/2022/08/mp_77782_0_0jpg.jpg)